Association of Neutrophil-to-Lymphocyte Ratio with Nutrition in Patients with Various Types of Malignant Tumors: A Multicenter Cross-Sectional Study
DOI: https://doi.org/10.2147/JIR.S401189
IF: 4.5
2023-03-28
Journal of Inflammation Research
Abstract:Lihua Kang, 1 Xiangliang Liu, 1 Wei Ji, 1 Kaiwen Zheng, 1 Yuguang Li, 2 Yanqiu Song, 1 Hua He, 1 Xiaomeng Wang, 1 Tingting Yang, 1 Meng Guan, 1 Ge Zhu, 1 Yangyang Gao, 1 Yanjie Guan, 1 Lei Wang, 1 Wei Li 1 1 Cancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China; 2 College of Instrumentation and Electrical Engineering, Jilin University, Changchun, Jilin Province, People's Republic of China Correspondence: Wei Li, Cancer Center, The First Hospital of Jilin University, No. 71 Xinmin Street, Changchun, 130021, People's Republic of China, Tel +86-13756661267, Email Aim: Neutrophil-to-lymphocyte ratio (NLR) is an index of systemic inflammation. This study is to clarify the role of NLR in body functional status, nutritional risk and nutritional status in the course of tumor. Methods: A multi-center cross-sectional study of patients with various types of malignant tumors was accrued from the whole country. There were 21,457 patients with completed clinical data, biochemical indicators, physical examination, the Patient-Generated Subjective Global Assessment (PG-SGA) and Nutrition Risk Screening 2002 (NRS2002) survey. Logistic regression analysis was used to figure out the influencing factors of NLR, and four models were established to evaluate the influence of NLR on body functions, nutritional risks and nutritional status. Results: Male patients, TNM stage IV, total bilirubin, hypertension and coronary atherosclerotic heart disease (CAHD) were independent predictors of NLR > 2.5. BMI, digestive systemic tumors and triglyceride negatively affect NLR in multivariable logistic regression. NLR was an independent predictor of Karnofsky Performance Scale (KPS), fat store deficit in all degrees, moderate and severe muscle deficit, mild fluid retention and PG-SGA grade. Conclusion: Male patients and those with hypertension and CAHD are prone to systemic inflammation. Systemic inflammation significantly degrades body function status and nutritional status, increases nutritional risk and influences fat and muscle metabolism in patients with malignant tumor. Improving the intervenable indicators such as elevating albumin and pre-albumin, decreasing total bilirubin and enhancing nutrition support are imperative. Obesity and triglyceride behave like anti-systemic inflammation, which is misleading due to reverse causation in the course of malignancy. Keywords: neutrophil-to-lymphocyte ratio, inflammation, tumor, nutrition, body function Currently, it is widely accepted that systemic inflammatory response has been shown to play an important role in the development and metastases of various types of malignant tumors. The inflammation in tumor microenvironment is characterized by the presence of host leucocytes both in stroma and tumor site. 1,2 It has been associated with unsatisfactory clinical outcomes, affecting tumor proliferation, angiogenesis, metastasis, and response to treatment. 3 Common systematic inflammatory markers used in clinical practice include neutrophil, C-reactive protein (CRP), the Glasgow Prognostic Score (GPS) or its modified version. 4 Besides, lymphocyte is regarded as the surrogate of cell-mediated immunity. The neutrophil-to-lymphocyte ratio (NLR) is derived from the absolute neutrophil count divided by the absolute lymphocyte count, which represents unique immune status under cancer circumstance. Thus, NLR should be a reliable, inexpensive and convenient marker. 5 In recent years, emerging evidence has demonstrated the role of NLR in evaluating treatment response and predicting prognosis in almost all kinds of cancer. 6–10 Nutrition-related status also plays an important role in malignant tumors. Malignant tumor patients, especially those of the digestive system tumors often suffer from an absence of appetite, nausea, diarrhea and abdominal discomfort, which cause tissue wasting and malnutrition, even cachexia. 11,12 The decreased body function and malnutrition may result in increased susceptibility to infection, an increased risk of complications, poor response and unplanned interruptions of treatments, a lower quality of life, reduced survival and higher health-care costs. 13–15 It can also contribute to tumor development through the suppression of anti-tumor immunity. 16 Systemic inflammatory response is clearly implicated in the progressive nutritional and functional decline in malignant tumor patients. The underlying metabolic alterations associated with systemic inflammation may contribute to the development -Abstract Truncated-
immunology